Trial Profile
INVega Is Studied In an Observational Design in the Netherlands.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms INVISION
- Sponsors Janssen-Cilag
- 06 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Dec 2009 Planned number of patients changed from 250 to 27 as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.